These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 21243265)

  • 21. H1N1 vaccine safety monitoring: beyond background rates.
    Destefano F; Tokars J
    Lancet; 2010 Apr; 375(9721):1146-7. PubMed ID: 19880171
    [No Abstract]   [Full Text] [Related]  

  • 22. Anti-ganglioside antibodies were not detected in human subjects infected with or vaccinated against 2009 pandemic influenza A (H1N1) virus.
    Lei T; Siu KL; Kok KH; Chan KH; Chan EY; Hung IF; To KK; Li PC; Zhou J; Zheng BJ; Yuen KY; Wang M; Jin DY
    Vaccine; 2012 Mar; 30(16):2605-10. PubMed ID: 22342549
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preliminary results: surveillance for Guillain-Barré syndrome after receipt of influenza A (H1N1) 2009 monovalent vaccine - United States, 2009-2010.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2010 Jun; 59(21):657-61. PubMed ID: 20520590
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Guillain-Barré syndrome after H1N1 influenza: a concern.
    Wiwanitkit V
    Neuroepidemiology; 2013; 40(4):295. PubMed ID: 23485791
    [No Abstract]   [Full Text] [Related]  

  • 25. The risk of Guillain-Barré syndrome associated with influenza A (H1N1) 2009 monovalent vaccine and 2009-2010 seasonal influenza vaccines: results from self-controlled analyses.
    Tokars JI; Lewis P; DeStefano F; Wise M; Viray M; Morgan O; Gargiullo P; Vellozzi C
    Pharmacoepidemiol Drug Saf; 2012 May; 21(5):546-52. PubMed ID: 22407672
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Guillain-Barre syndrome during the 2009-2010 H1N1 influenza vaccination campaign: population-based surveillance among 45 million Americans.
    Wise ME; Viray M; Sejvar JJ; Lewis P; Baughman AL; Connor W; Danila R; Giambrone GP; Hale C; Hogan BC; Meek JI; Murphree R; Oh JY; Reingold A; Tellman N; Conner SM; Singleton JA; Lu PJ; DeStefano F; Fridkin SK; Vellozzi C; Morgan OW
    Am J Epidemiol; 2012 Jun; 175(11):1110-9. PubMed ID: 22582209
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pandemic vaccines and small excess of Guillain-Barre cases.
    BMJ; 2013 Mar; 346():f1714. PubMed ID: 23516147
    [No Abstract]   [Full Text] [Related]  

  • 28. Invited commentary: Influenza vaccine and Guillain-Barre syndrome--is there a risk?
    Nelson KE
    Am J Epidemiol; 2012 Jun; 175(11):1129-32. PubMed ID: 22582208
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Safety of adjuvanted pandemic influenza A (H1N1) 2009 vaccines.
    DeStefano F; Vellozzi C; Schonberger LB; Chen RT
    BMJ; 2011 Jul; 343():d4159. PubMed ID: 21750073
    [No Abstract]   [Full Text] [Related]  

  • 30. Simultaneous development of acute disseminated encephalomyelitis and Guillain-Barré syndrome associated with H1N1 09 influenza vaccination.
    Hoshino T; Uchiyama Y; Ito E; Osawa S; Ohashi T
    Intern Med; 2012; 51(12):1595-8. PubMed ID: 22728497
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Should I have an H1N1 flu vaccination after Guillain-Barre syndrome?
    Price LC
    BMJ; 2009 Sep; 339():b3577. PubMed ID: 19740925
    [No Abstract]   [Full Text] [Related]  

  • 32. Atypical forms of Guillain-Barré syndrome and H1N1-influenza vaccination.
    Shaikh AG; Termsarasab P; Nwankwo C; Rao-Frisch A; Katirji B
    Vaccine; 2012 May; 30(22):3251-4. PubMed ID: 22429755
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risk of Guillain-Barré syndrome after 2010-2011 influenza vaccination.
    Galeotti F; Massari M; D'Alessandro R; Beghi E; Chiò A; Logroscino G; Filippini G; Benedetti MD; Pugliatti M; Santuccio C; Raschetti R;
    Eur J Epidemiol; 2013 May; 28(5):433-44. PubMed ID: 23543123
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hospital discharge data for Guillain-Barré syndrome and influenza A (H1N1) vaccine adverse events.
    Jones TF; McMillian M; Boothe E; Hanna S; Ingram LA
    Emerg Infect Dis; 2010 Sep; 16(9):1500-1. PubMed ID: 20735949
    [No Abstract]   [Full Text] [Related]  

  • 35. [Guillain-Barré syndrome after exposure to influenza].
    Hartung HP; Keller-Stanislawski B; Hughes RA; Lehmann HC
    Nervenarzt; 2012 Jun; 83(6):714-30. PubMed ID: 22528062
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Guillain-Barre syndrome, influenzalike illnesses, and influenza vaccination during seasons with and without circulating A/H1N1 viruses.
    Grimaldi-Bensouda L; Alpérovitch A; Besson G; Vial C; Cuisset JM; Papeix C; Lyon-Caen O; Benichou J; Rossignol M;
    Am J Epidemiol; 2011 Aug; 174(3):326-35. PubMed ID: 21652600
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The self-controlled case series method for evaluating safety of vaccines.
    Hawken S; Wilson KR
    Med J Aust; 2012 Nov; 197(10):578-9. PubMed ID: 23163690
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Guillain-Barré syndrome following the 2009 pandemic monovalent and seasonal trivalent influenza vaccination campaigns in Spain from 2009 to 2011: outcomes from active surveillance by a neurologist network, and records from a country-wide hospital discharge database.
    Alcalde-Cabero E; Almazán-Isla J; García López FJ; Ara-Callizo JR; Avellanal F; Casasnovas C; Cemillán C; Cuadrado JI; Duarte J; Fernández-Pérez MD; Fernández Ó; Merino JA; Montero RG; Montero D; Pardo J; Rodríguez-Rivera FJ; Ruiz-Tovar M; de Pedro-Cuesta J;
    BMC Neurol; 2016 May; 16():75. PubMed ID: 27206524
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influenza vaccination and Guillain Barré syndrome.
    Haber P; DeStefano F
    Clin Immunol; 2003 Dec; 109(3):359; author reply 360-1. PubMed ID: 14697752
    [No Abstract]   [Full Text] [Related]  

  • 40. Events supposedly attributable to vaccination or immunization during pandemic influenza A (H1N1) vaccination campaigns in Latin America and the Caribbean.
    Ropero-Álvarez AM; Whittembury A; Bravo-Alcántara P; Kurtis HJ; Danovaro-Holliday MC; Velandia-González M
    Vaccine; 2015 Jan; 33(1):187-92. PubMed ID: 25444798
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.